Header Logo

Karen Wernli, PhD

TitleSenior Investigator
InstitutionKaiser Permanente Washington
DepartmentWashington Health Research Institute
Address1730 Minor Ave
Seattle WA 98101
ORCID ORCID Icon0000-0001-7945-0327 Additional info
vCardDownload vCard
    Other Positions
    TitleProfessor
    InstitutionKaiser Permanente Bernard J. Tyson School of Medicine
    DepartmentHealth Systems Science

    TitleAffiliate Professor
    InstitutionUniversity of Washington
    DepartmentEpidemiology; Health Systems and Population Health


    Collapse Overview 
    Collapse overview
    Biography

    Karen Wernli, PhD, is a cancer epidemiologist and health services researcher whose work focuses on incorporating patient-centered outcomes to improve cancer care along the cancer care continuum from prevention to survivorship. Her works spans several types of cancer, including lung, breast, and colorectal, and studying the impact of cancer in special populations, like in adolescent and young adults (AYA). Her research strives to answer critical questions at the confluence of patients’ needs and clinical priorities. Overall, her research has resulted in > $15.5 million in external research funding, >115 peer-reviewed publications, and > 70 presentations at national conferences, symposia, and other public venues.

    Dr. Wernli is a leader in multilevel intervention studies to improve lung cancer screening. She is currently conducting a pragmatic clinical trial funded by the National Cancer Institute to test two multilevel interventions to improve adherence to annual lung cancer screening at Kaiser Permanente Washington (R01CA262015). Study interventions were developed using a mixed-methods approach, including patient and stakeholder engagement and human-centered design methods, to determine gaps for interventions, relevant features of interventions, and design concepts. Further, Dr. Wernli is also leading a pilot grant from Alliance in Clinical Trials in Oncology to develop interventions to improve timely follow-up after a positive lung cancer screening scan. The purpose of the pilot grant is to develop a larger project within the NCI Community Oncology Research Program (NCORP).

    Dr. Wernli is a leader in the use of breast imaging in women with prior breast cancer including in the use of breast magnetic resonance imaging (MRI). Dr. Wernli recently completed a Patient-Centered Outcomes Research Institute (PCORI) project that compared to mammography for women already treated for breast cancer. Called Surveillance Imaging Modalities for Breast Cancer Assessment (SIMBA), the study used data from the Breast Cancer Surveillance Consortium (BCSC) and engaged patients and stakeholders to determine the best information for patient and physician decision-making. Dr. Wernli’s team translated that information into a new decision aid for breast cancer survivors. PCORI has recognized this work nationally and pointed to SIMBA as a model for effective patient engagement.

    Dr. Wernli’s other breast cancer projects include a National Cancer Institute (NCI)-funded study to examine trends and outcomes related to the mandatory notification of breast density that has been enacted in many states with Dr. Natasha Stout from Harvard University. She led research to determine temporal trends in breast MRI by indication for the scans. The analysis relied on national claims-based data across all 50 states.

    Dr. Wernli is leading patient-centered research in AYA populations. She is currently a Project Co-Lead with KP Southern California researcher Dr. Erin Hahn and Veteran’s Affairs researcher Dr. Neetu Chawla on a NCI-funded program project to evaluate health service utilization in early survivorship for AYA populations. The research is intended to identify multilevel gaps in healthcare utilization for forthcoming interventions. Previously, Dr. Wernli launched the Clare Project with KPWHRI researchers, including Dr. Marlaine Figueroa Gray, to understand patient, caregiver, and provider perspectives regarding medical decision making in patients with advanced cancer. Using novel methods, all perspectives were garnered through social media recruitment. With NCI-funding, she has evaluated temporal trends and regional variation in end-of-life care in AYA cancer populations using national claims-based data.

    Finally, Dr. Wernli is developing a research within clinical research studies. She is currently the Cancer Care Delivery Research lead at Kaiser Permanente Washington. She is currently Principal Investigator of KPWA of a multisite study of flu and COVID vaccine effectiveness funded by the Centers for Disease Control.

    Dr. Wernli is a member of American Society for Preventive Oncology, Society for Epidemiologic Research, American Society for Clinical Oncology, and American Association for Cancer Research. She is a standing reviewer for American Cancer Society, and routinely reviews grants for the National Institute of Health. She is also an affiliate associate professor of population and epidemiology at the University of Washington.

    Collapse Research 
    Collapse research activities and funding
    R01CA262015     (WERNLI, KAREN J)Jul 15, 2021 - Jun 30, 2026
    NIH
    Multilevel Interventions to Increase Adherence to Lung Cancer Screening
    Role: Principal Investigator

    P01CA233432     (KUSHI, LAWRENCE H)Sep 15, 2020 - Jun 30, 2025
    NIH
    Clinical Care Gaps and Unmet Needs in Adolescent and Young Adult (AYA) Cancers
    Role: Co-Investigator

    R21CA205309     (WERNLI, KAREN J)May 9, 2016 - Apr 30, 2019
    NIH
    National trends in end of life care for adolescent and young adult cancer patients
    Role: Principal Investigator

    CE-1304-6656     (WERNLI, KAREN)Oct 1, 2013 - Jun 30, 2018
    Patient-Centered Outcomes Research Institute
    Title of Project: Comparative effectiveness of surveillance imaging strategies in breast cancer
    Role: Principal Investigator

    U54CA163261     (CHUBAK, JESSICA)Sep 1, 2011 - May 31, 2018
    NIH
    Studying Colorectal Cancer Effectiveness of Screening Strategies (SuCCESS)
    Role: Co-Investigator

    R03CA159080     (WERNLI, KAREN J)Apr 1, 2011 - Mar 31, 2014
    NIH
    Mammographic Breast Density and Ovarian Cancer
    Role: Principal Investigator

    K12HS019482     (SULLIVAN, SEAN D)Jul 1, 2010 - Jun 30, 2013
    NIH
    UW Centers for Comparative and Health Systems Effectiveness Training Program
    Role: Co-Investigator

    Collapse Featured Content 
    Collapse Twitter

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Hood N, Flannery B, Gaglani M, Beeram M, Wernli K, Jackson ML, Martin ET, Monto AS, Zimmerman R, Raviotta J, Belongia EA, McLean HQ, Kim S, Patel MM, Chung JR. Influenza Vaccine Effectiveness Among Children: 2011-2020. Pediatrics. 2023 04 01; 151(4). PMID: 36960655; PMCID: PMC10071433.
      Citations:    Fields:    Translation:HumansCellsPHPublic Health
    2. Lowry KP, Ichikawa L, Hubbard RA, Buist DSM, Bowles EJA, Henderson LM, Kerlikowske K, Specht JM, Sprague BL, Wernli KJ, Lee JM. Variation in second breast cancer risk after primary invasive cancer by time since primary cancer diagnosis and estrogen receptor status. Cancer. 2023 Feb 15. PMID: 36789739.
      Citations:    Fields:    Translation:Humans
    3. Su YR, Buist DS, Lee JM, Ichikawa L, Miglioretti DL, Aiello Bowles EJ, Wernli KJ, Kerlikowske K, Tosteson A, Lowry KP, Henderson LM, Sprague BL, Hubbard RA. Performance of statistical and machine learning risk prediction models for surveillance benefits and failures in breast cancer survivors. Cancer Epidemiol Biomarkers Prev. 2023 Jan 25. PMID: 36697364.
      Citations:    Fields:    Translation:Humans
    4. Tartof SY, Xie F, Yadav R, Wernli KJ, Martin ET, Belongia EA, Gaglani M, Zimmerman RK, Talbot HK, Thornburg N, Flannery B, Chung JR, US Flu VE Network Investigators. Prior SARS-CoV-2 Infection and COVID-19 Vaccine Effectiveness against Outpatient Illness during Widespread Circulation of SARS-CoV-2 Omicron Variant, US Flu VE Network. medRxiv. 2023 Jan 11. PMID: 36711929; PMCID: PMC9882409.
      Citations:    
    5. Shafer L, Ahmed F, Kim S, Wernli KJ, Jackson ML, Nowalk MP, Bear T, Zimmerman RK, Martin ET, Monto AS, Gaglani M, Reis M, Chung JR, Flannery B, Uzicanin A. Relationship between Telework Experience and Presenteeism during COVID-19 Pandemic, United States, March-November 2020. Emerg Infect Dis. 2023 Feb; 29(2):278-285. PMID: 36599411; PMCID: PMC9881775.
      Citations: 1     Fields:    Translation:HumansCellsPHPublic Health
    6. Price AM, Flannery B, Talbot HK, Grijalva CG, Wernli KJ, Phillips CH, Monto AS, Martin ET, Belongia EA, McLean HQ, Gaglani M, Mutnal M, Geffel KM, Nowalk MP, Tartof SY, Florea A, McLean C, Kim SS, Patel MM, Chung JR. Influenza Vaccine Effectiveness Against Influenza A(H3N2)-Related Illness in the United States During the 2021-2022 Influenza Season. Clin Infect Dis. 2022 Dec 12. PMID: 36504336.
      Citations: 3     Fields:    Translation:HumansCellsPHPublic Health
    7. Jayasekera J, Zhao A, Schechter C, Lowry K, Yeh JM, Schwartz MD, O'Neill S, Wernli KJ, Stout N, Mandelblatt J, Kurian AW, Isaacs C. Reassessing the Benefits and Harms of Risk-Reducing Medication Considering the Persistent Risk of Breast Cancer Mortality in Estrogen Receptor-Positive Breast Cancer. J Clin Oncol. 2023 Feb 01; 41(4):859-870. PMID: 36455167; PMCID: PMC9901948.
      Citations:    Fields:    Translation:Humans
    8. Tosteson ANA, Schifferdecker KE, Smith RE, Wernli KJ, Zhao W, Kaplan CP, Buist DSM, Henderson LM, Sprague BL, Onega T, Budesky J, Jackson-Nefertiti G, Johnson D, Miglioretti DL, Kerlikowske K. Women's Breast Cancer Screening Confidence by Screening Modality and Breast Density: A Breast Cancer Surveillance Consortium Survey Study. J Womens Health (Larchmt). 2022 11; 31(11):1547-1556. PMID: 36356184; PMCID: PMC9700351.
      Citations:    Fields:    Translation:HumansPHPublic Health
    9. Ho TH, Bissell MCS, Lee CI, Lee JM, Sprague BL, Tosteson ANA, Wernli KJ, Henderson LM, Kerlikowske K, Miglioretti DL. Prioritizing Screening Mammograms for Immediate Interpretation and Diagnostic Evaluation on the Basis of Risk for Recall. J Am Coll Radiol. 2022 Oct 20. PMID: 36273501.
      Citations:    Fields:    Translation:HumansPHPublic Health
    10. Kim SS, Chung JR, Talbot HK, Grijalva CG, Wernli KJ, Kiniry E, Martin ET, Monto AS, Belongia EA, McLean HQ, Gaglani M, Mamawala M, Nowalk MP, Moehling Geffel K, Tartof SY, Florea A, Lee JS, Tenforde MW, Patel MM, Flannery B, Strain Surveillance and Emerging Variants Team, Bentz ML, Burgin A, Burroughs M, Davis ML, Howard D, Lacek K, Madden JC, Nobles S, Padilla J, Sheth M. Effectiveness of two and three mRNA COVID-19 vaccine doses against Omicron- and Delta-Related outpatient illness among adults, October 2021-February 2022. Influenza Other Respir Viruses. 2022 Nov; 16(6):975-985. PMID: 36825251; PMCID: PMC9353375.
      Citations: 3     Fields:    Translation:HumansCells
    11. Wernli KJ, Smith RE, Henderson LM, Zhao W, Durham DD, Schifferdecker K, Kaplan C, Buist DSM, Kerlikowske K, Miglioretti DL, Onega T, Alsheik NH, Sprague BL, Jackson-Nefertiti G, Budesky J, Johnson D, Tosteson ANA. Decision quality and regret with treatment decisions in women with breast cancer: Pre-operative breast MRI and breast density. Breast Cancer Res Treat. 2022 Aug; 194(3):607-616. PMID: 35723793.
      Citations:    Fields:    Translation:Humans
    12. Li ZN, Liu F, Jefferson S, Horner L, Carney P, Johnson MDL, King JP, Martin ET, Zimmerman RK, Wernli K, Gaglani M, Thompson M, Flannery B, Stevens J, Tumpey T, Levine MZ. Multiplex Detection of Antibody Landscapes to SARS-CoV-2/Influenza/Common Human Coronaviruses Following Vaccination or Infection with SARS-CoV-2 and Influenza. Clin Infect Dis. 2022 Jun 10. PMID: 35684961; PMCID: PMC9214136.
      Citations: 2     Fields:    Translation:HumansCellsPHPublic Health
    13. Lowry KP, Callaway KA, Lee JM, Zhang F, Ross-Degnan D, Wharam JF, Kerlikowske K, Wernli KJ, Kurian AW, Henderson LM, Stout NK. Trends in Annual Surveillance Mammography Participation Among Breast Cancer Survivors From 2004 to 2016. J Natl Compr Canc Netw. 2022 04; 20(4):379-386.e9. PMID: 35390766.
      Citations:    Fields:    Translation:Humans
    14. Haas CB, Hsu L, Lampe JW, Wernli KJ, Lindström S. Cross-ancestry Genome-wide Association Studies of Sex Hormone Concentrations in Pre- and Postmenopausal Women. Endocrinology. 2022 Apr 01; 163(4). PMID: 35192695; PMCID: PMC8962449.
      Citations:    Fields:    Translation:Humans
    15. Smith RE, Sprague B, Henderson LM, Kerlikowske K, Miglioretti DL, Buist DSM, Wernli KJ, Onega T, Schifferdecker K, Jackson-Nefertiti G, Johnson D, Budesky J, Tosteson ANA. Breast Density Knowledge in a Screening Mammography Population Exposed to Density Notification. J Am Coll Radiol. 2022 Mar 24. PMID: 35341697.
      Citations: 2     Fields:    Translation:HumansPHPublic Health
    16. Chung JR, Kim SS, Kondor RJ, Smith C, Budd AP, Tartof SY, Florea A, Talbot HK, Grijalva CG, Wernli KJ, Phillips CH, Monto AS, Martin ET, Belongia EA, McLean HQ, Gaglani M, Reis M, Geffel KM, Nowalk MP, DaSilva J, Keong LM, Stark TJ, Barnes JR, Wentworth DE, Brammer L, Burns E, Fry AM, Patel MM, Flannery B. Interim Estimates of 2021-22 Seasonal Influenza Vaccine Effectiveness - United States, February 2022. MMWR Morb Mortal Wkly Rep. 2022 Mar 11; 71(10):365-370. PMID: 35271561; PMCID: PMC8911998.
      Citations: 15     Fields:    Translation:HumansCellsPHPublic Health
    17. Holman A, Kross E, Crothers K, Cole A, Wernli K, Triplette M. Patient Perspectives on Longitudinal Adherence to Lung Cancer Screening. Chest. 2022 Feb 08. PMID: 35149081.
      Citations: 1     Fields:    Translation:HumansPHPublic Health
    18. Schousboe JT, Sprague BL, Abraham L, O'Meara ES, Onega T, Advani S, Henderson LM, Wernli KJ, Zhang D, Miglioretti DL, Braithwaite D, Kerlikowske K. Cost-Effectiveness of Screening Mammography Beyond Age 75 Years : A Cost-Effectiveness Analysis. Ann Intern Med. 2022 Jan; 175(1):11-19. PMID: 34807717.
      Citations: 2     Fields:    Translation:HumansPHPublic Health
    19. Conley CC, Wernli KJ, Knerr S, Li T, Leppig K, Ehrlich K, Farrell D, Gao H, Bowles EJA, Graham AL, Luta G, Jayasekera J, Mandelblatt JS, Schwartz MD, O'Neill SC. Using Protection Motivation Theory to Predict Intentions for Breast Cancer Risk Management: Intervention Mechanisms from a Randomized Controlled Trial. J Cancer Educ. 2021 Nov 23. PMID: 34813048.
      Citations:    Fields:    Translation:Humans
    20. Zhang D, Abraham L, Sprague BL, Onega T, Advani S, Demb J, Miglioretti DL, Henderson LM, Wernli KJ, Walter LC, Kerlikowske K, Schousboe JT, Chrischilles E, Braithwaite D, O'Meara ES, Breast Cancer Surveillance Consortium. Mammography adherence in relation to function-related indicators in older women. Prev Med. 2022 Jan; 154:106869. PMID: 34762965; PMCID: PMC8724400.
      Citations:    Fields:    Translation:HumansPHPublic Health
    21. Onega T, Zhu W, Kerlikowske K, Miglioretti DL, Lee CI, Henderson LM, Tosteson ANA, Wernli KJ, diFlorio R, Weaver DL, Buist DSM. Preoperative MRI in breast cancer: effect of breast density on biopsy rate and yield. Breast Cancer Res Treat. 2022 Jan; 191(1):177-190. PMID: 34686934.
      Citations: 3     Fields:    Translation:Humans
    22. Lowry KP, Bissell M, Miglioretti DL, Kerlikowske K, Alsheik N, Macarol T, Bowles EJA, Buist DSM, Tosteson ANA, Henderson L, Herschorn SD, Wernli KJ, Weaver DL, Stout NK, Sprague BL. Breast Biopsy Recommendations and Breast Cancers Diagnosed during the COVID-19 Pandemic. Radiology. 2021 Oct 19; 211808. PMID: 34665032; PMCID: PMC8544262.
      Citations: 8     Fields:    Translation:HumansPHPublic Health
    23. Thompson MJ, Suchsland MZ, Hardy V, Lavallee DC, Lord S, Devine EB, Jarvik JG, Findlay S, Trikalinos TA, Walter FM, Chou R, Green BB, Wernli KJ, Fitzpatrick AL, Bossuyt PM. Patient-centred outcomes of imaging tests: recommendations for patients, clinicians and researchers. BMJ Qual Saf. 2021 Oct 06. PMID: 34615733.
      Citations: 1     Fields:    
    24. Bowles EJA, O'Neill SC, Li T, Knerr S, Mandelblatt JS, Schwartz MD, Jayasekera J, Leppig K, Ehrlich K, Farrell D, Gao H, Graham AL, Luta G, Wernli KJ. Effect of a Randomized Trial of a Web-Based Intervention on Patient-Provider Communication About Breast Density. J Womens Health (Larchmt). 2021 11; 30(11):1529-1537. PMID: 34582721.
      Citations:    Fields:    Translation:Humans
    25. Kerlavage AR, Kirchhoff AC, Guidry Auvil JM, Sharpless NE, Davis KL, Reilly K, Reaman G, Penberthy L, Deapen D, Hwang A, Durbin EB, Gallotto SL, Aplenc R, Volchenboum SL, Heath AP, Aronow BJ, Zhang J, Vaske O, Alonzo TA, Nathan PC, Poynter JN, Armstrong G, Hahn EE, Wernli KJ, Greene C, DiGiovanna J, Resnick AC, Shalley ER, Nadaf S, Kibbe WA. Cancer Informatics for Cancer Centers: Scientific Drivers for Informatics, Data Science, and Care in Pediatric, Adolescent, and Young Adult Cancer. JCO Clin Cancer Inform. 2021 08; 5:881-896. PMID: 34428097.
      Citations: 1     Fields:    Translation:HumansCellsPHPublic Health
    26. Schifferdecker KE, Vaclavik D, Wernli KJ, Buist DSM, Kerlikowske K, Sprague BL, Henderson LM, Johnson D, Budesky J, Jackson-Nefertiti G, Miglioretti DL, Tosteson ANA. Women's considerations and experiences for breast cancer screening and surveillance during the COVID-19 pandemic in the United States: A focus group study. Prev Med. 2021 10; 151:106542. PMID: 34217409.
      Citations: 4     Fields:    Translation:HumansCellsPHPublic Health
    27. Zhang D, Abraham L, Demb J, Miglioretti DL, Advani S, Sprague BL, Henderson LM, Onega T, Wernli KJ, Walter LC, Kerlikowske K, Schousboe JT, O'Meara ES, Braithwaite D, Breast Cancer Surveillance Consortium. Function-related Indicators and Outcomes of Screening Mammography in Older Women: Evidence from the Breast Cancer Surveillance Consortium Cohort. Cancer Epidemiol Biomarkers Prev. 2021 Aug; 30(8):1582-1590. PMID: 34078641.
      Citations: 3     Fields:    Translation:Humans
    28. Wernli KJ, Tuzzio L, Brush S, Ehrlich K, Gao H, Anderson ML, Palazzo L. Understanding Patient and Clinical Stakeholder Perspectives to Improve Adherence to Lung Cancer Screening. Perm J. 2021 Jun 02; 25. PMID: 35348073; PMCID: PMC8817936.
      Citations:    Fields:    Translation:HumansPHPublic Health
    29. Lee JM, Ichikawa LE, Wernli KJ, Bowles E, Specht JM, Kerlikowske K, Miglioretti DL, Lowry KP, Tosteson ANA, Stout NK, Houssami N, Onega T, Buist DSM. Digital Mammography and Breast Tomosynthesis Performance in Women with a Personal History of Breast Cancer, 2007-2016. Radiology. 2021 Aug; 300(2):290-300. PMID: 34003059; PMCID: PMC8328154.
      Citations: 3     Fields:    Translation:HumansPHPublic Health
    30. Miglioretti DL, Bissell MCS, Kerlikowske K, Buist DSM, Cummings SR, Henderson LM, Onega T, O'Meara ES, Rauscher GH, Sprague BL, Tosteson ANA, Wernli KJ, Lee JM, Lee CI. Assessment of a Risk-Based Approach for Triaging Mammography Examinations During Periods of Reduced Capacity. JAMA Netw Open. 2021 03 01; 4(3):e211974. PMID: 33764423; PMCID: PMC7994953.
      Citations: 4     Fields:    Translation:HumansCellsPHPublic Health
    31. Wernli KJ, Knerr S, Li T, Leppig K, Ehrlich K, Farrell D, Gao H, Bowles EJA, Graham AL, Luta G, Jayasekera J, Mandelblatt JS, Schwartz MD, O'Neill SC. Effect of Personalized Breast Cancer Risk Tool on Chemoprevention and Breast Imaging: ENGAGED-2 Trial. JNCI Cancer Spectr. 2021 Feb; 5(1):pkaa114. PMID: 33554037; PMCID: PMC7853161.
      Citations: 1     Fields:    Translation:Humans
    32. Wernli KJ, Bowles EA, Knerr S, Leppig KA, Ehrlich K, Gao H, Schwartz MD, O'Neill SC. Characteristics Associated with Participation in ENGAGED 2 - A Web-based Breast Cancer Risk Communication and Decision Support Trial. Perm J. 2020 12; 24:1-4. PMID: 33482952; PMCID: PMC7849258.
      Citations: 2     Fields:    Translation:Humans
    33. Wernli KJ, Callaway KA, Henderson LM, Kerlikowske K, Lee JM, Ross-Degnan D, Wallace JK, Wharam JF, Zhang F, Stout NK. Trends in screening breast magnetic resonance imaging use among US women, 2006 to 2016. Cancer. 2020 12 15; 126(24):5293-5302. PMID: 32985694.
      Citations: 5     Fields:    Translation:Humans
    34. Haas CB, Nekhlyudov L, Lee JM, Javid SH, Bush M, Johnson D, Gleason T, Kaufman C, Specht J, Stitham S, Wernli KJ. Surveillance for second breast cancer events in women with a personal history of breast cancer using breast MRI: a systematic review and meta-analysis. Breast Cancer Res Treat. 2020 Jun; 181(2):255-268. PMID: 32303988; PMCID: PMC7262783.
      Citations: 4     Fields:    Translation:HumansPHPublic Health
    35. Warner ET, Kennedy M, Maschke A, Hopkins MF, Wernli K, Gunn CM. Evaluation of existing patient educational materials and development of a brochure for women with dense breasts. Breast. 2020 Apr; 50:81-84. PMID: 32086135; PMCID: PMC7110420.
      Citations: 4     Fields:    Translation:Humans
    36. Buist DSM, Ichikawa L, Wernli KJ, Lee CI, Henderson LM, Kerlikowske K, Bowles EJA, Miglioretti DL, Specht J, Rauscher GH, Sprague BL, Onega T, Lee JM. Facility Variability in Examination Indication Among Women With Prior Breast Cancer: Implications and the Need for Standardization. J Am Coll Radiol. 2020 Jun; 17(6):755-764. PMID: 32004483; PMCID: PMC7275918.
      Citations: 4     Fields:    Translation:HumansPHPublic Health
    37. Mahorter SS, Knerr S, Bowles EJA, Wernli KJ, Gao H, Schwartz MD, O'Neill SC. Prior breast density awareness, knowledge, and communication in a health system-embedded behavioral intervention trial. Cancer. 2020 04 15; 126(8):1614-1621. PMID: 31977078; PMCID: PMC7103492.
      Citations: 6     Fields:    Translation:HumansPHPublic Health
    38. Schifferdecker KE, Tosteson ANA, Kaplan C, Kerlikowske K, Buist DSM, Henderson LM, Johnson D, Jaworski J, Jackson-Nefertiti G, Ehrlich K, Marsh MW, Vu L, Onega T, Wernli KJ. Knowledge and Perception of Breast Density, Screening Mammography, and Supplemental Screening: in Search of "Informed". J Gen Intern Med. 2020 06; 35(6):1654-1660. PMID: 31792869; PMCID: PMC7280373.
      Citations: 14     Fields:    Translation:HumansPHPublic Health
    39. Kerlikowske K, Sprague BL, Tosteson ANA, Wernli KJ, Rauscher GH, Johnson D, Buist DSM, Onega T, Henderson LM, O'Meara ES, Miglioretti DL. Strategies to Identify Women at High Risk of Advanced Breast Cancer During Routine Screening for Discussion of Supplemental Imaging. JAMA Intern Med. 2019 Sep 01; 179(9):1230-1239. PMID: 31260054; PMCID: PMC6604099.
      Citations: 21     Fields:    
    40. Henderson LM, Ichikawa L, Buist DSM, Lee JM, Bush M, Johnson D, Onega T, Nekhlyudov L, Kerlikowske K, Miglioretti DL, Sprague BL, Wernli KJ. Patterns of Breast Imaging Use Among Women with a Personal History of Breast Cancer. J Gen Intern Med. 2019 10; 34(10):2098-2106. PMID: 31410813; PMCID: PMC6816668.
      Citations: 4     Fields:    Translation:Humans
    41. Wernli KJ, Ichikawa L, Kerlikowske K, Buist DSM, Brandzel SD, Bush M, Johnson D, Henderson LM, Nekhlyudov L, Onega T, Sprague BL, Lee JM, Lehman CD, Miglioretti DL. Surveillance Breast MRI and Mammography: Comparison in Women with a Personal History of Breast Cancer. Radiology. 2019 08; 292(2):311-318. PMID: 31161975; PMCID: PMC6694722.
      Citations: 12     Fields:    Translation:Humans
    42. Breen N, Skinner CS, Zheng Y, Inrig S, Corley DA, Beaber EF, Garcia M, Chubak J, Doubeni C, Quinn VP, Haas JS, Li CI, Wernli KJ, Klabunde CN. Time to Follow-up After Colorectal Cancer Screening by Health Insurance Type. Am J Prev Med. 2019 May; 56(5):e143-e152. PMID: 31003603.
      Citations: 3     Fields:    Translation:Humans
    43. Haas CB, Phipps AI, Hajat A, Chubak J, Wernli KJ. Time to fecal immunochemical test completion for colorectal cancer screening. Am J Manag Care. 2019 Apr; 25(4):174-180. PMID: 30986014.
      Citations: 3     Fields:    Translation:Humans
    44. Knerr S, Bowles EJA, Leppig KA, Buist DSM, Gao H, Wernli KJ. Trends in BRCA Test Utilization in an Integrated Health System, 2005-2015. J Natl Cancer Inst. 2019 Feb 08. PMID: 30753636.
      Citations: 16     Fields:    Translation:Humans
    45. Arasu VA, Miglioretti DL, Sprague BL, Alsheik NH, Buist DSM, Henderson LM, Herschorn SD, Lee JM, Onega T, Rauscher GH, Wernli KJ, Lehman CD, Kerlikowske K. Population-Based Assessment of the Association Between Magnetic Resonance Imaging Background Parenchymal Enhancement and Future Primary Breast Cancer Risk. J Clin Oncol. 2019 Apr 20; 37(12):954-963. PMID: 30625040.
      Citations: 27     Fields:    Translation:Humans
    46. Beaber EF, Sprague BL, Tosteson ANA, Haas JS, Onega T, Schapira MM, McCarthy AM, Li CI, Herschorn SD, Lehman CD, Wernli KJ, Barlow WE. Multilevel Predictors of Continued Adherence to Breast Cancer Screening Among Women Ages 50-74 Years in a Screening Population. J Womens Health (Larchmt). 2018 Nov 27. PMID: 30481098.
      Citations: 3     Fields:    Translation:HumansPHPublic Health
    47. Chubak J, McLerran D, Zheng Y, Singal AG, Corley DA, Doria-Rose VP, Doubeni CA, Kamineni A, Haas JS, Halm EA, Skinner CS, Zauber AG, Wernli KJ, Beaber EF. Receipt of Colonoscopy Following Diagnosis of Advanced Adenomas: An Analysis within Integrated Healthcare Delivery Systems. Cancer Epidemiol Biomarkers Prev. 2019 Jan; 28(1):91-98. PMID: 30459208.
      Citations: 9     Fields:    Translation:Humans
    48. Lee CI, Zhu W, Onega TL, Germino J, O'Meara ES, Lehman CD, Henderson LM, Haas JS, Kerlikowske K, Sprague BL, Rauscher GH, Tosteson ANA, Alford-Teaster J, Wernli KJ, Miglioretti DL. The Effect of Digital Breast Tomosynthesis Adoption on Facility-Level Breast Cancer Screening Volume. AJR Am J Roentgenol. 2018 Nov; 211(5):957-963. PMID: 30235000.
      Citations: 4     Fields:    Translation:HumansPHPublic Health
    49. Figueroa Gray M, Ludman EJ, Beatty T, Rosenberg AR, Wernli KJ. Balancing Hope and Risk Among Adolescent and Young Adult Cancer Patients with Late-Stage Cancer: A Qualitative Interview Study. J Adolesc Young Adult Oncol. 2018 Dec; 7(6):673-680. PMID: 30096254.
      Citations: 10     Fields:    Translation:Humans
    50. Roth JA, Carter-Harris L, Brandzel S, Buist DSM, Wernli KJ. A qualitative study exploring patient motivations for screening for lung cancer. PLoS One. 2018; 13(7):e0196758. PMID: 29975709.
      Citations: 12     Fields:    Translation:Humans
    51. Buist DSM, Abraham L, Lee CI, Lee JM, Lehman C, O'Meara ES, Stout NK, Henderson LM, Hill D, Wernli KJ, Haas JS, Tosteson ANA, Kerlikowske K, Onega T. Breast Biopsy Intensity and Findings Following Breast Cancer Screening in Women With and Without a Personal History of Breast Cancer. JAMA Intern Med. 2018 04 01; 178(4):458-468. PMID: 29435556.
      Citations: 12     Fields:    Translation:Humans
    52. Onega T, Zhu W, Weiss JE, Goodrich M, Tosteson ANA, DeMartini W, Virnig BA, Henderson LM, Buist DSM, Wernli KJ, Kerlikowske K, Hubbard RA. Preoperative breast MRI and mortality in older women with breast cancer. Breast Cancer Res Treat. 2018 Jul; 170(1):149-157. PMID: 29516372.
      Citations: 6     Fields:    Translation:Humans
    53. Singal AG, Corley DA, Kamineni A, Garcia M, Zheng Y, Doria-Rose PV, Quinn VP, Jensen CD, Chubak J, Tiro J, Doubeni CA, Ghai NR, Skinner CS, Wernli K, Halm EA. Patterns and predictors of repeat fecal immunochemical and occult blood test screening in four large health care systems in the United States. Am J Gastroenterol. 2018 May; 113(5):746-754. PMID: 29487413.
      Citations: 10     Fields:    Translation:HumansPHPublic Health
    54. Miles R, Wan F, Onega TL, Lenderink-Carpenter A, O'Meara ES, Zhu W, Henderson LM, Haas JS, Hill DA, Tosteson ANA, Wernli KJ, Alford-Teaster J, Lee JM, Lehman CD, Lee CI. Underutilization of Supplemental Magnetic Resonance Imaging Screening Among Patients at High Breast Cancer Risk. J Womens Health (Larchmt). 2018 06; 27(6):748-754. PMID: 29341851.
      Citations: 15     Fields:    Translation:Humans
    55. Henderson LM, Hubbard RA, Zhu W, Weiss J, Wernli KJ, Goodrich ME, Kerlikowske K, DeMartini W, Ozanne EM, Onega T. Preoperative Breast Magnetic Resonance Imaging Use by Breast Density and Family History of Breast Cancer. J Womens Health (Larchmt). 2018 08; 27(8):987-993. PMID: 29334616.
      Citations: 1     Fields:    Translation:HumansPHPublic Health
    56. Greene SM, Brandzel S, Wernli KJ. From Principles to Practice: Real-World Patient and Stakeholder Engagement in Breast Cancer Research. Perm J. 2018; 22:17-232. PMID: 29911967.
      Citations: 5     Fields:    Translation:Humans
    57. Hill DA, Haas JS, Wellman R, Hubbard RA, Lee CI, Alford-Teaster J, Wernli KJ, Henderson LM, Stout NK, Tosteson ANA, Kerlikowske K, Onega T. Utilization of breast cancer screening with magnetic resonance imaging in community practice. J Gen Intern Med. 2018 Mar; 33(3):275-283. PMID: 29214373.
      Citations: 14     Fields:    Translation:Humans
    58. Onega T, Weiss JE, Goodrich ME, Zhu W, DeMartini WB, Kerlikowske K, Ozanne E, Tosteson ANA, Henderson LM, Buist DSM, Wernli KJ, Herschorn SD, Hotaling E, O'Donoghue C, Hubbard R. Relationship between preoperative breast MRI and surgical treatment of non-metastatic breast cancer. J Surg Oncol. 2017 Dec; 116(8):1008-1015. PMID: 29127715.
      Citations: 7     Fields:    Translation:Humans
    59. Sakoda LC, Henderson LM, Caverly TJ, Wernli KJ, Katki HA. Applying Risk Prediction Models to Optimize Lung Cancer Screening: Current Knowledge, Challenges, and Future Directions. Curr Epidemiol Rep. 2017 Dec; 4(4):307-320. PMID: 29531893.
      Citations: 7     
    60. Lee JM, Ichikawa L, Valencia E, Miglioretti DL, Wernli K, Buist DSM, Kerlikowske K, Henderson LM, Sprague BL, Onega T, Rauscher GH, Lehman CD. Performance Benchmarks for Screening Breast MR Imaging in Community Practice. Radiology. 2017 10; 285(1):44-52. PMID: 28582633.
      Citations: 19     Fields:    Translation:Humans
    61. Carter-Harris L, Brandzel S, Wernli KJ, Roth JA, Buist DSM. A qualitative study exploring why individuals opt out of lung cancer screening. Fam Pract. 2017 04 01; 34(2):239-244. PMID: 28122849.
      Citations: 38     Fields:    Translation:HumansPHPublic Health
    62. Sethi R, Buchlak QD, Yanamadala V, Anderson ML, Baldwin EA, Mecklenburg RS, Leveque JC, Edwards AM, Shea M, Ross L, Wernli KJ. A systematic multidisciplinary initiative for reducing the risk of complications in adult scoliosis surgery. J Neurosurg Spine. 2017 Jun; 26(6):744-750. PMID: 28362214.
      Citations: 15     Fields:    Translation:Humans
    63. Balasubramanian BA, Garcia MP, Corley DA, Doubeni CA, Haas JS, Kamineni A, Quinn VP, Wernli K, Zheng Y, Skinner CS. Racial/ethnic differences in obesity and comorbidities between safety-net- and non safety-net integrated health systems. Medicine (Baltimore). 2017 Mar; 96(11):e6326. PMID: 28296752.
      Citations: 11     Fields:    Translation:Humans
    64. Knerr S, Wernli KJ, Leppig K, Ehrlich K, Graham AL, Farrell D, Evans C, Luta G, Schwartz MD, O'Neill SC. A web-based personalized risk communication and decision-making tool for women with dense breasts: Design and methods of a randomized controlled trial within an integrated health care system. Contemp Clin Trials. 2017 05; 56:25-33. PMID: 28257920.
      Citations: 8     Fields:    Translation:Humans
    65. Wernli KJ, Arao RF, Hubbard RA, Sprague BL, Alford-Teaster J, Haas JS, Henderson L, Hill D, Lee CI, Tosteson ANA, Onega T. Change in Breast Cancer Screening Intervals Since the 2009 USPSTF Guideline. J Womens Health (Larchmt). 2017 08; 26(8):820-827. PMID: 28177856.
      Citations: 6     Fields:    Translation:HumansPHPublic Health
    66. Brandzel S, Rosenberg DE, Johnson D, Bush M, Kerlikowske K, Onega T, Henderson L, Nekhlyudov L, DeMartini W, Wernli KJ. Women's experiences and preferences regarding breast imaging after completing breast cancer treatment. Patient Prefer Adherence. 2017; 11:199-204. PMID: 28203064.
      Citations: 13     
    67. Shortreed SM, Johnson E, Rutter CM, Kamineni A, Wernli KJ, Chubak J. Cohort restriction based on prior enrollment: Examining potential biases in estimating cancer and mortality risk. Obs Stud. 2016 Aug; 2:51-64. PMID: 28530002.
      Citations: 1     
    68. Wernli KJ, Brenner AT, Rutter CM, Inadomi JM. Reply. Gastroenterology. 2016 09; 151(3):564. PMID: 27496674.
      Citations:    Fields:    
    69. Wernli KJ, Henrikson NB, Morrison CC, Nguyen M, Pocobelli G, Blasi PR. Screening for Skin Cancer in Adults: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force. JAMA. 2016 Jul 26; 316(4):436-47. PMID: 27458949.
      Citations: 40     Fields:    Translation:Humans
    70. Onega T, Weiss JE, Buist DS, Tosteson AN, Henderson LM, Kerlikowske K, Goodrich ME, O'Donoghue C, Wernli KJ, DeMartini WB, Virnig BA, Bennette CS, Hubbard RA. Breast MRI in the Diagnostic and Preoperative Workup Among Medicare Beneficiaries With Breast Cancer. Med Care. 2016 07; 54(7):719-24. PMID: 27111752.
      Citations: 3     Fields:    Translation:Humans
    71. Hubbard RA, Johnson E, Chubak J, Wernli KJ, Kamineni A, Bogart A, Rutter CM. Accounting for misclassification in electronic health records-derived exposures using generalized linear finite mixture models. Health Serv Outcomes Res Methodol. 2017 Jun; 17(2):101-112. PMID: 28943779.
      Citations: 5     
    72. Hubbard RA, O'Meara ES, Henderson LM, Hill D, Braithwaite D, Haas JS, Lee CI, Sprague BL, Alford-Teaster J, Tosteson ANA, Wernli KJ, Onega T. Multilevel factors associated with long-term adherence to screening mammography in older women in the U.S. Prev Med. 2016 08; 89:169-177. PMID: 27261409.
      Citations: 15     Fields:    Translation:HumansPHPublic Health
    73. Onega T, Tosteson AN, Weiss J, Alford-Teaster J, Hubbard RA, Henderson LM, Kerlikowske K, Goodrich ME, O'Donoghue C, Wernli KJ, DeMartini WB, Virnig BA. Costs of diagnostic and preoperative workup with and without breast MRI in older women with a breast cancer diagnosis. BMC Health Serv Res. 2016 Feb 27; 16:76. PMID: 26920552.
      Citations: 10     Fields:    Translation:Humans
    74. Johnson DS, Bush MT, Brandzel S, Wernli KJ. The patient voice in research-evolution of a role. Res Involv Engagem. 2016; 2:6. PMID: 29062507.
      Citations: 28     
    75. Lee AY, Ichikawa L, Lee JM, Lee CI, DeMartini WB, Joe BN, Wernli KJ, Sprague BL, Herschorn SD, Lehman CD. Concordance of BI-RADS Assessments and Management Recommendations for Breast MRI in Community Practice. AJR Am J Roentgenol. 2016 Jan; 206(1):211-6. PMID: 26700354.
      Citations:    Fields:    Translation:HumansPHPublic Health
    76. Haas JS, Hill DA, Wellman RD, Hubbard RA, Lee CI, Wernli KJ, Stout NK, Tosteson AN, Henderson LM, Alford-Teaster JA, Onega TL. Disparities in the use of screening magnetic resonance imaging of the breast in community practice by race, ethnicity, and socioeconomic status. Cancer. 2016 Feb 15; 122(4):611-7. PMID: 26709819.
      Citations: 23     Fields:    Translation:Humans
    77. Wernli KJ, Brenner AT, Rutter CM, Inadomi JM. Risks Associated With Anesthesia Services During Colonoscopy. Gastroenterology. 2016 Apr; 150(4):888-94; quiz e18. PMID: 26709032.
      Citations: 59     Fields:    Translation:Humans
    78. Henderson LM, Miglioretti DL, Kerlikowske K, Wernli KJ, Sprague BL, Lehman CD. Breast Cancer Characteristics Associated With Digital Versus Film-Screen Mammography for Screen-Detected and Interval Cancers. AJR Am J Roentgenol. 2015 Sep; 205(3):676-84. PMID: 26295657.
      Citations: 16     Fields:    Translation:HumansPHPublic Health
    79. Wieneke AE, Bowles EJ, Cronkite D, Wernli KJ, Gao H, Carrell D, Buist DS. Validation of natural language processing to extract breast cancer pathology procedures and results. J Pathol Inform. 2015; 6:38. PMID: 26167382.
      Citations: 18     
    80. Gallagher LG, Li W, Ray RM, Romano ME, Wernli KJ, Gao DL, Thomas DB, Checkoway H. Occupational exposures and risk of stomach and esophageal cancers: update of a cohort of female textile workers in Shanghai, China. Am J Ind Med. 2015 Mar; 58(3):267-75. PMID: 25611949.
      Citations: 7     Fields:    Translation:HumansPHPublic Health
    81. Li W, Ray RM, Thomas DB, Davis S, Yost M, Breslow N, Gao DL, Fitzgibbons ED, Camp JE, Wong E, Wernli KJ, Checkoway H. Shift work and breast cancer among women textile workers in Shanghai, China. Cancer Causes Control. 2015 Jan; 26(1):143-50. PMID: 25421377.
      Citations: 24     Fields:    Translation:HumansPHPublic Health
    82. Onega T, Weiss J, Kerlikowske K, Wernli K, Buist DS, Henderson LM, Goodrich M, Alford-Teaster J, Virnig B, Tosteson AN, DeMartini W, Hubbard R. The influence of race/ethnicity and place of service on breast reconstruction for Medicare beneficiaries with mastectomy. Springerplus. 2014; 3:416. PMID: 25140292.
      Citations: 8     
    83. Lee CI, Ichikawa L, Rochelle MC, Kerlikowske K, Miglioretti DL, Sprague BL, DeMartini WB, Wernli KJ, Joe BN, Yankaskas BC, Lehman CD. Breast MRI BI-RADS assessments and abnormal interpretation rates by clinical indication in US community practices. Acad Radiol. 2014 Nov; 21(11):1370-6. PMID: 25126973.
      Citations: 5     Fields:    Translation:Humans
    84. Tiro JA, Kamineni A, Levin TR, Zheng Y, Schottinger JS, Rutter CM, Corley DA, Skinner CS, Chubak J, Doubeni CA, Halm EA, Gupta S, Wernli KJ, Klabunde C. The colorectal cancer screening process in community settings: a conceptual model for the population-based research optimizing screening through personalized regimens consortium. Cancer Epidemiol Biomarkers Prev. 2014 Jul; 23(7):1147-58. PMID: 24917182.
      Citations: 44     Fields:    Translation:Humans
    85. Cohen-Cline H, Wernli KJ, Bradford SC, Boles-Hall M, Grossman DC. Use of interactive voice response to improve colorectal cancer screening. Med Care. 2014 Jun; 52(6):496-9. PMID: 24638119.
      Citations: 14     Fields:    Translation:Humans
    86. Wernli KJ, Hubbard RA, Johnson E, Chubak J, Kamineni A, Green BB, Rutter CM. Patterns of colorectal cancer screening uptake in newly eligible men and women. Cancer Epidemiol Biomarkers Prev. 2014 Jul; 23(7):1230-7. PMID: 24793956.
      Citations: 11     Fields:    Translation:Humans
    87. Johnson KE, Kamineni A, Fuller S, Olmstead D, Wernli KJ. How the provenance of electronic health record data matters for research: a case example using system mapping. EGEMS (Wash DC). 2014; 2(1):1058. PMID: 25821838.
      Citations: 21     
    88. Bowles EJ, Wernli KJ, Gray HJ, Bogart A, Delate T, O'Keeffe-Rosetti M, Nekhlyudov L, Loggers ET. Diffusion of Intraperitoneal Chemotherapy in Women with Advanced Ovarian Cancer in Community Settings 2003-2008: The Effect of the NCI Clinical Recommendation. Front Oncol. 2014; 4:43. PMID: 24653978.
      Citations: 6     
    89. Wernli KJ, DeMartini WB, Ichikawa L, Lehman CD, Onega T, Kerlikowske K, Henderson LM, Geller BM, Hofmann M, Yankaskas BC. Patterns of breast magnetic resonance imaging use in community practice. JAMA Intern Med. 2014 Jan; 174(1):125-32. PMID: 24247555.
      Citations: 68     Fields:    Translation:Humans
    90. Wernli KJ, O'Meara ES, Kerlikowske K, Miglioretti DL, Muller CY, Onega T, Sprague BL, Henderson LM, Buist DS. Investigation of mammographic breast density as a risk factor for ovarian cancer. J Natl Cancer Inst. 2014 Jan; 106(1):djt341. PMID: 24309005.
      Citations: 1     Fields:    Translation:Humans
    91. Li W, Ray RM, Thomas DB, Yost M, Davis S, Breslow N, Gao DL, Fitzgibbons ED, Camp JE, Wong E, Wernli KJ, Checkoway H. Occupational exposure to magnetic fields and breast cancer among women textile workers in Shanghai, China. Am J Epidemiol. 2013 Oct 01; 178(7):1038-45. PMID: 24043439.
      Citations: 6     Fields:    Translation:HumansPHPublic Health
    92. O'Meara ES, Zhu W, Hubbard RA, Braithwaite D, Kerlikowske K, Dittus KL, Geller B, Wernli KJ, Miglioretti DL. Mammographic screening interval in relation to tumor characteristics and false-positive risk by race/ethnicity and age. Cancer. 2013 Nov 15; 119(22):3959-67. PMID: 24037812.
      Citations: 9     Fields:    Translation:Humans
    93. Wernli KJ, Kitahara CM, Tamers SL, Al-Temimi MH, Braithwaite D. Undertaking cancer research in international settings: report from the american society for preventive oncology special interest group on international issues in cancer. Cancer Epidemiol Biomarkers Prev. 2013 Sep; 22(9):1638-41. PMID: 23845714.
      Citations:    Fields:    Translation:Humans
    94. Kerlikowske K, Zhu W, Hubbard RA, Geller B, Dittus K, Braithwaite D, Wernli KJ, Miglioretti DL, O'Meara ES. Outcomes of screening mammography by frequency, breast density, and postmenopausal hormone therapy. JAMA Intern Med. 2013 May 13; 173(9):807-16. PMID: 23552817.
      Citations: 70     Fields:    Translation:HumansPHPublic Health
    95. Wernli KJ, Inadomi JM. Anesthesia for colonoscopy: too much of a good thing? JAMA Intern Med. 2013 Apr 08; 173(7):556-8. PMID: 23479078.
      Citations: 2     Fields:    Translation:Humans
    96. Wernli KJ, Rutter CM, Dachman AH, Zafar HM. Suspected extracolonic neoplasms detected on CT colonography: literature review and possible outcomes. Acad Radiol. 2013 Jun; 20(6):667-74. PMID: 23465379.
      Citations: 5     Fields:    Translation:Humans
    97. Braithwaite D, Zhu W, Hubbard RA, O'Meara ES, Miglioretti DL, Geller B, Dittus K, Moore D, Wernli KJ, Mandelblatt J, Kerlikowske K. Screening outcomes in older US women undergoing multiple mammograms in community practice: does interval, age, or comorbidity score affect tumor characteristics or false positive rates? J Natl Cancer Inst. 2013 Mar 06; 105(5):334-41. PMID: 23385442.
      Citations: 46     Fields:    Translation:HumansPHPublic Health
    98. Passarelli MN, Phipps AI, Potter JD, Makar KW, Coghill AE, Wernli KJ, White E, Chan AT, Hutter CM, Peters U, Newcomb PA. Common single-nucleotide polymorphisms in the estrogen receptor ß promoter are associated with colorectal cancer survival in postmenopausal women. Cancer Res. 2013 Jan 15; 73(2):767-75. PMID: 23149914.
      Citations: 19     Fields:    Translation:HumansCells
    99. Carlos RC, Buist DS, Wernli KJ, Swan JS. Patient-centered outcomes in imaging: quantifying value. J Am Coll Radiol. 2012 Oct; 9(10):725-8. PMID: 23025867.
      Citations: 7     Fields:    Translation:Humans
    100. Schur EA, Elmore JE, Onega T, Wernli KJ, Sickles EA, Haneuse S. The impact of obesity on follow-up after an abnormal screening mammogram. Cancer Epidemiol Biomarkers Prev. 2012 Feb; 21(2):327-36. PMID: 22144503.
      Citations:    Fields:    Translation:HumansPHPublic Health
    101. Coghill AE, Newcomb PA, Chia VM, Zheng Y, Wernli KJ, Passarelli MN, Potter JD. Pre-diagnostic NSAID use but not hormone therapy is associated with improved colorectal cancer survival in women. Br J Cancer. 2011 Mar 01; 104(5):763-8. PMID: 21304527.
      Citations: 12     Fields:    Translation:Humans
    102. Wernli KJ, Aiello Bowles EJ, Haneuse S, Elmore JG, Buist DS. Timing of follow-up after abnormal screening and diagnostic mammograms. Am J Manag Care. 2011 Feb; 17(2):162-7. PMID: 21473665.
      Citations: 12     Fields:    Translation:HumansPHPublic Health
    103. Burnett-Hartman AN, Newcomb PA, Mandelson MT, Adams SV, Wernli KJ, Shadman M, Wurscher MA, Makar KW. Colorectal polyp type and the association with charred meat consumption, smoking, and microsomal epoxide hydrolase polymorphisms. Nutr Cancer. 2011; 63(4):583-92. PMID: 21598178.
      Citations: 14     Fields:    Translation:HumansAnimals
    104. Checkoway H, Ray RM, Lundin JI, Astrakianakis G, Seixas NS, Camp JE, Wernli KJ, Fitzgibbons ED, Li W, Feng Z, Gao DL, Thomas DB. Lung cancer and occupational exposures other than cotton dust and endotoxin among women textile workers in Shanghai, China. Occup Environ Med. 2011 Jun; 68(6):425-9. PMID: 21131604.
      Citations: 7     Fields:    Translation:HumansPHPublic Health
    105. Wernli KJ, Hampton JM, Trentham-Dietz A, Newcomb PA. Use of antidepressants and NSAIDs in relation to mortality in long-term breast cancer survivors. Pharmacoepidemiol Drug Saf. 2011 Feb; 20(2):131-7. PMID: 21254283.
      Citations: 20     Fields:    Translation:Humans
    106. Braithwaite D, Wernli KJ, Anton-Culver H, Engstrom P, Greenberg ER, Meyskens F. Opportunities for cancer epidemiology and control in low- and middle-income countries: a report from the american society for preventive oncology international cancer prevention interest group. Cancer Epidemiol Biomarkers Prev. 2010 Jul; 19(7):1665-7. PMID: 20615883.
      Citations: 1     Fields:    Translation:Humans
    107. Wernli KJ, Newcomb PA, Wang Y, Makar KW, Shadman M, Chia VM, Burnett-Hartman A, Wurscher MA, Zheng Y, Mandelson MT. Body size, IGF and growth hormone polymorphisms, and colorectal adenomas and hyperplastic polyps. Growth Horm IGF Res. 2010 Aug; 20(4):305-9. PMID: 20580999.
      Citations: 15     Fields:    Translation:Humans
    108. Astrakianakis G, Seixas NS, Ray R, Camp JE, Gao DL, Feng Z, Li W, Wernli KJ, Fitzgibbons ED, Thomas DB, Checkoway H. Re: Lung cancer risk among female textile workers exposed to endotoxin. J Natl Cancer Inst. 2010 Jun 16; 102(12):913-4. PMID: 20445162.
      Citations: 6     Fields:    Translation:HumansPHPublic Health
    109. Wong EY, Ray R, Gao DL, Wernli KJ, Li W, Fitzgibbons ED, Camp JE, Heagerty PJ, De Roos AJ, Holt VL, Thomas DB, Checkoway H. Physical activity, physical exertion, and miscarriage risk in women textile workers in Shanghai, China. Am J Ind Med. 2010 May; 53(5):497-505. PMID: 20340112.
      Citations: 11     Fields:    Translation:HumansPHPublic Health
    110. Wernli KJ, Wang Y, Zheng Y, Potter JD, Newcomb PA. The relationship between gravidity and parity and colorectal cancer risk. J Womens Health (Larchmt). 2009 Jul; 18(7):995-1001. PMID: 19575687.
      Citations: 13     Fields:    Translation:Humans
    111. Shadman M, Newcomb PA, Hampton JM, Wernli KJ, Trentham-Dietz A. Non-steroidal anti-inflammatory drugs and statins in relation to colorectal cancer risk. World J Gastroenterol. 2009 May 21; 15(19):2336-9. PMID: 19452574.
      Citations: 12     Fields:    Translation:Humans
    112. Wernli KJ, Hampton JM, Trentham-Dietz A, Newcomb PA. Antidepressant medication use and breast cancer risk. Pharmacoepidemiol Drug Saf. 2009 Apr; 18(4):284-90. PMID: 19226540.
      Citations: 18     Fields:    Translation:HumansPHPublic Health
    113. Wong EY, Ray RM, Gao DL, Wernli KJ, Li W, Fitzgibbons ED, Camp JE, Astrakianakis G, Heagerty PJ, De Roos AJ, Holt VL, Thomas DB, Checkoway H. Dust and chemical exposures, and miscarriage risk among women textile workers in Shanghai, China. Occup Environ Med. 2009 Mar; 66(3):161-8. PMID: 18805889.
      Citations: 3     Fields:    Translation:HumansPHPublic Health
    114. Wernli KJ, Ray RM, Gao DL, Fitzgibbons ED, Camp JE, Astrakianakis G, Seixas N, Li W, De Roos AJ, Feng Z, Thomas DB, Checkoway H. Occupational risk factors for endometrial cancer among textile workers in Shanghai, China. Am J Ind Med. 2008 Sep; 51(9):673-9. PMID: 18626909.
      Citations: 6     Fields:    Translation:HumansPHPublic Health
    115. Rosenblatt KA, Gao DL, Ray RM, Nelson ZC, Wernli KJ, Li W, Thomas DB. Oral contraceptives and the risk of all cancers combined and site-specific cancers in Shanghai. Cancer Causes Control. 2009 Feb; 20(1):27-34. PMID: 18704712.
      Citations: 12     Fields:    Translation:Humans
    116. Wernli KJ, Newcomb PA, Hampton JM, Trentham-Dietz A, Egan KM. Inverse association of NSAID use and ovarian cancer in relation to oral contraceptive use and parity. Br J Cancer. 2008 Jun 03; 98(11):1781-3. PMID: 18506182.
      Citations: 24     Fields:    Translation:Humans
    117. Wernli KJ, Ray RM, Gao DL, Fitzgibbons ED, Camp JE, Astrakianakis G, Seixas N, Wong EY, Li W, De Roos AJ, Feng Z, Thomas DB, Checkoway H. Occupational exposures and ovarian cancer in textile workers. Epidemiology. 2008 Mar; 19(2):244-50. PMID: 18300714.
      Citations: 7     Fields:    Translation:HumansCellsPHPublic Health
    118. Wernli KJ, Newcomb PA, Hampton JM, Trentham-Dietz A, Egan KM. Hormone therapy and ovarian cancer: incidence and survival. Cancer Causes Control. 2008 Aug; 19(6):605-13. PMID: 18264784.
      Citations: 13     Fields:    Translation:Humans
    119. Rosenblatt KA, Gao DL, Ray RM, Nelson ZC, Wernli KJ, Li W, Thomas DB. Monthly injectable contraceptives and the risk of all cancers combined and site-specific cancers in Shanghai. Contraception. 2007 Jul; 76(1):40-4. PMID: 17586135.
      Citations: 1     Fields:    Translation:Humans
    120. Ray RM, Gao DL, Li W, Wernli KJ, Astrakianakis G, Seixas NS, Camp JE, Fitzgibbons ED, Feng Z, Thomas DB, Checkoway H. Occupational exposures and breast cancer among women textile workers in Shanghai. Epidemiology. 2007 May; 18(3):383-92. PMID: 17435449.
      Citations: 12     Fields:    Translation:HumansPHPublic Health
    121. Astrakianakis G, Seixas NS, Ray R, Camp JE, Gao DL, Feng Z, Li W, Wernli KJ, Fitzgibbons ED, Thomas DB, Checkoway H. Lung cancer risk among female textile workers exposed to endotoxin. J Natl Cancer Inst. 2007 Mar 07; 99(5):357-64. PMID: 17341727.
      Citations: 35     Fields:    Translation:HumansPHPublic Health
    122. Rosenblatt KA, Gao DL, Ray RM, Rowland MR, Nelson ZC, Wernli KJ, Li W, Thomas DB. Induced abortions and the risk of all cancers combined and site-specific cancers in Shanghai. Cancer Causes Control. 2006 Dec; 17(10):1275-80. PMID: 17111259.
      Citations: 8     Fields:    Translation:Humans
    123. Wernli KJ, Astrakianakis G, Camp JE, Ray RM, Chang CK, Li GD, Thomas DB, Checkoway H, Seixas NS. Development of a job exposure matrix (JEM) for the textile industry in Shanghai, China. J Occup Environ Hyg. 2006 Oct; 3(10):521-9. PMID: 16908453.
      Citations: 18     Fields:    Translation:HumansPHPublic Health
    124. Wernli KJ, Ray RM, Gao DL, De Roos AJ, Checkoway H, Thomas DB. Menstrual and reproductive factors in relation to risk of endometrial cancer in Chinese women. Cancer Causes Control. 2006 Sep; 17(7):949-55. PMID: 16841262.
      Citations: 28     Fields:    Translation:Humans
    125. Chang CK, Astrakianakis G, Thomas DB, Seixas NS, Camp JE, Ray RM, Gao DL, Wernli KJ, Li W, Fitzgibbons ED, Vaughan TL, Checkoway H. Risks of biliary tract cancer and occupational exposures among Shanghai women textile workers: a case-cohort study. Am J Ind Med. 2006 Aug; 49(8):690-8. PMID: 16830349.
      Citations: 4     Fields:    Translation:HumansPHPublic Health
    126. Li W, Ray RM, Gao DL, Fitzgibbons ED, Seixas NS, Camp JE, Wernli KJ, Astrakianakis G, Feng Z, Thomas DB, Checkoway H. Occupational risk factors for pancreatic cancer among female textile workers in Shanghai, China. Occup Environ Med. 2006 Dec; 63(12):788-93. PMID: 16847032.
      Citations: 11     Fields:    Translation:HumansPHPublic Health
    127. Gold LS, De Roos AJ, Ray RM, Wernli K, Fitzgibbons ED, Gao DL, Astrakianakis G, Feng Z, Thomas D, Checkoway H. Brain tumors and occupational exposures in a cohort of female textile workers in Shanghai, China. Scand J Work Environ Health. 2006 Jun; 32(3):178-84. PMID: 16804619.
      Citations: 5     Fields:    Translation:HumansPHPublic Health
    128. Wernli KJ, Fitzgibbons ED, Ray RM, Gao DL, Li W, Seixas NS, Camp JE, Astrakianakis G, Feng Z, Thomas DB, Checkoway H. Occupational risk factors for esophageal and stomach cancers among female textile workers in Shanghai, China. Am J Epidemiol. 2006 Apr 15; 163(8):717-25. PMID: 16467414.
      Citations: 14     Fields:    Translation:HumansPHPublic Health
    129. Li W, Ray RM, Gao DL, Fitzgibbons ED, Seixas NS, Camp JE, Wernli KJ, Astrakianakis G, Feng Z, Thomas DB, Checkoway H. Occupational risk factors for nasopharyngeal cancer among female textile workers in Shanghai, China. Occup Environ Med. 2006 Jan; 63(1):39-44. PMID: 16361404.
      Citations: 22     Fields:    Translation:HumansPHPublic Health
    130. Chang CK, Astrakianakis G, Thomas DB, Seixas NS, Ray RM, Gao DL, Wernli KJ, Fitzgibbons ED, Vaughan TL, Checkoway H. Occupational exposures and risks of liver cancer among Shanghai female textile workers--a case-cohort study. Int J Epidemiol. 2006 Apr; 35(2):361-9. PMID: 16373377.
      Citations: 10     Fields:    Translation:HumansPHPublic Health
    131. De Roos AJ, Ray RM, Gao DL, Wernli KJ, Fitzgibbons ED, Ziding F, Astrakianakis G, Thomas DB, Checkoway H. Colorectal cancer incidence among female textile workers in Shanghai, China: a case-cohort analysis of occupational exposures. Cancer Causes Control. 2005 Dec; 16(10):1177-88. PMID: 16215868.
      Citations: 11     Fields:    Translation:HumansPHPublic Health
    132. Wong EY, Ray R, Gao DL, Wernli KJ, Li W, Fitzgibbons ED, Feng Z, Thomas DB, Checkoway H. Reproductive history, occupational exposures, and thyroid cancer risk among women textile workers in Shanghai, China. Int Arch Occup Environ Health. 2006 Mar; 79(3):251-8. PMID: 16220287.
      Citations: 25     Fields:    Translation:HumansPHPublic Health
    133. Wernli KJ, Ray RM, Gao DL, Thomas DB, Checkoway H. Cancer among women textile workers in Shanghai, China: overall incidence patterns, 1989-1998. Am J Ind Med. 2003 Dec; 44(6):595-9. PMID: 14635236.
      Citations: 14     Fields:    Translation:HumansPHPublic HealthCTClinical Trials
    134. Camp JE, Seixas NS, Wernli K, Fitzgibbons D, Astrakianakis G, Thomas DB, Gao DL, Checkoway H. Development of a cancer research study in the Shanghai textile industry. Int J Occup Environ Health. 2003 Oct-Dec; 9(4):347-56. PMID: 14664489.
      Citations: 4     Fields:    Translation:HumansPHPublic Health
    Concepts (301)
    Explore
    _
    Co-Authors (12)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _
    Physical Neighbors
    _
    -->

    © 2024 Kaiser Permanente